Atlas Trials

Dose Ranging and Dose Frequency of LIPO-102

Clinical trial NCT00918814 · COMPLETED

Trial details

NCT number
NCT00918814
Sponsor
Neothetics, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Subcutaneous Adipose Tissue Reduction
Start date
2009-06-01
Primary completion
2010-02-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.